当前位置: 首页 > 新闻 > 信息荟萃
编号:10529134
基因治疗成功了
http://www.100md.com 2003年10月18日
     LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-CalvoScience Oct 17 2003: 415-419.We have previously shown correction of X-linked severe combined immunodeficiency [SCID-X1, also known as {gamma} chain ({gamma}c) deficiency] in 9 out of 10 patients by retrovirus-mediated {gamma}c gene transfer into autologous CD34 bone marrow cells. However, almost 3 years after gene therapy, uncontrolled exponential clonal proliferation of mature T cells (with {gamma}{delta}+ or {alpha}ß+ T cell receptors) has occurred in the two youngest patients. Both patients' clones showed retrovirus vector integration in proximity to the LMO2 proto-oncogene promoter, leading to aberrant transcription and expression of LMO2. Thus, retrovirus vector insertion can trigger deregulated premalignant cell proliferation with unexpected frequency, most likely driven by retrovirus enhancer activity on the LMO2 gene promoter.

    You can read more from:

    [Abstract] [Full Text] [PDF] [Supporting Online Material], 百拇医药